These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 16557362)

  • 1. Gene-dosage effect on chromosome 21 transcriptome in trisomy 21: implication in Down syndrome cognitive disorders.
    Kahlem P
    Behav Genet; 2006 May; 36(3):416-28. PubMed ID: 16557362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosome 21 and down syndrome: from genomics to pathophysiology.
    Antonarakis SE; Lyle R; Dermitzakis ET; Reymond A; Deutsch S
    Nat Rev Genet; 2004 Oct; 5(10):725-38. PubMed ID: 15510164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mental retardation in Down syndrome: from gene dosage imbalance to molecular and cellular mechanisms.
    Rachidi M; Lopes C
    Neurosci Res; 2007 Dec; 59(4):349-69. PubMed ID: 17897742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic mechanisms involved in the phenotype of Down syndrome.
    Patterson D
    Ment Retard Dev Disabil Res Rev; 2007; 13(3):199-206. PubMed ID: 17910086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 10 years of Genomics, chromosome 21, and Down syndrome.
    Antonarakis SE
    Genomics; 1998 Jul; 51(1):1-16. PubMed ID: 9693027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse models of cognitive disabilities in trisomy 21 (Down syndrome).
    Roubertoux PL; Carlier M
    Am J Med Genet C Semin Med Genet; 2010 Nov; 154C(4):400-16. PubMed ID: 20981769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosage-dependent over-expression of genes in the trisomic region of Ts1Cje mouse model for Down syndrome.
    Amano K; Sago H; Uchikawa C; Suzuki T; Kotliarova SE; Nukina N; Epstein CJ; Yamakawa K
    Hum Mol Genet; 2004 Jul; 13(13):1333-40. PubMed ID: 15138197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping of the human holocarboxylase synthetase gene (HCS) to the Down syndrome critical region of chromosome 21q22.
    Blouin JL; Duriaux Saïl G; Antonarakis SE
    Ann Genet; 1996; 39(3):185-8. PubMed ID: 8839893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human chromosome 21/Down syndrome gene function and pathway database.
    Nikolaienko O; Nguyen C; Crinc LS; Cios KJ; Gardiner K
    Gene; 2005 Dec; 364():90-8. PubMed ID: 16310977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mental retardation and associated neurological dysfunctions in Down syndrome: a consequence of dysregulation in critical chromosome 21 genes and associated molecular pathways.
    Rachidi M; Lopes C
    Eur J Paediatr Neurol; 2008 May; 12(3):168-82. PubMed ID: 17933568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Annotation of human chromosome 21 for relevance to Down syndrome: gene structure and expression analysis.
    Gardiner K; Slavov D; Bechtel L; Davisson M
    Genomics; 2002 Jun; 79(6):833-43. PubMed ID: 12036298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis (Part III).
    Cheon MS; Kim SH; Ovod V; Kopitar Jerala N; Morgan JI; Hatefi Y; Ijuin T; Takenawa T; Lubec G
    Amino Acids; 2003; 24(1-2):127-34. PubMed ID: 12624744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical mapping of chromosome 21.
    Patterson D; Rahmani Z; Donaldson D; Gardiner K; Jones C
    Prog Clin Biol Res; 1993; 384():33-50. PubMed ID: 8115406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis (Part I).
    Cheon MS; Kim SH; Yaspo ML; Blasi F; Aoki Y; Melen K; Lubec G
    Amino Acids; 2003; 24(1-2):111-7. PubMed ID: 12624742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trisomy 21: from chromosomes to mental retardation.
    Roubertoux PL; Kerdelhué B
    Behav Genet; 2006 May; 36(3):346-54. PubMed ID: 16596471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and cellular mechanisms elucidating neurocognitive basis of functional impairments associated with intellectual disability in Down syndrome.
    Rachidi M; Lopes C
    Am J Intellect Dev Disabil; 2010 Mar; 115(2):83-112. PubMed ID: 20441388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional genomics of the Down syndrome.
    Nizetić D
    Croat Med J; 2001 Aug; 42(4):421-7. PubMed ID: 11471193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mapping of the Down syndrome phenotype on chromosome 21.
    Sinet PM; Théophile D; Rahmani Z; Chettouh Z; Blouin JL; Prieur M; Noel B; Delabar JM
    Prog Clin Biol Res; 1993; 384():63-86. PubMed ID: 8115408
    [No Abstract]   [Full Text] [Related]  

  • 19. Gene dosage imbalance of human chromosome 21 in mouse embryonic stem cells differentiating to neurons.
    Wang CC; Kazuki Y; Oshimura M; Ikeo K; Gojobori T
    Gene; 2011 Aug; 481(2):93-101. PubMed ID: 21549184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S100 protein and Down syndrome.
    Marks A; Allore R
    Bioessays; 1990 Aug; 12(8):381-3. PubMed ID: 2146955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.